There are at least 8 subtypes of mGluRs in the brain, which have been segregated into three groups. These receptors have predominantly been shown to attenuate glutamate release and modulate normal synaptic transmission in the brain. However, recently evidence suggests that mGluRs expressed in dentate granule cells are also involved in dysfunctional synaptic plasticity after status epilepticus and may contribute to the development of epilepsy. The current proposal is designed to test the hypothesis that the development of hyperexcitability depends specifically upon dysfunctional synaptic inhibition mediated by group III mGluRs. Using selective pharmacological agents and genetically manipulated knockout mice, we will identify a specific mGluR subtype that modulates granule cell excitation of GABAergic interneurons in the dentate. Genomic microarray technology will be used to measure changes in mGluR expression during epileptogenesis. We will also examine mGluR- mediated dysfunction in a chronic model of epilepsy. We expect the results of these studies will lead to an improved understanding of the role of mGluRs in the brain and their possible contribution to epileptogenesis. Further, we anticipate that knowledge gained from this work may also prevent novel treatment strategies for controlling stroke- or trauma-induced brain damage.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
1F32NS043032-01
Application #
6446498
Study Section
Special Emphasis Panel (ZRG1-BDCN-1 (20))
Program Officer
Jacobs, Margaret
Project Start
2002-05-01
Project End
Budget Start
2002-05-01
Budget End
2003-04-30
Support Year
1
Fiscal Year
2002
Total Cost
$44,212
Indirect Cost
Name
Emory University
Department
Pharmacology
Type
Schools of Medicine
DUNS #
042250712
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Bough, Kristopher J; Mott, David D; Dingledine, Raymond J (2004) Medial perforant path inhibition mediated by mGluR7 is reduced after status epilepticus. J Neurophysiol 92:1549-57